Schonfeld Strategic Advisors LLC lessened its stake in shares of Integer Holdings Co. (NYSE:ITGR – Free Report) by 7.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,600 shares of the medical equipment provider’s stock after selling 223 shares during the quarter. Schonfeld Strategic Advisors LLC’s holdings in Integer were worth $345,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Emerald Mutual Fund Advisers Trust boosted its holdings in shares of Integer by 0.8% in the fourth quarter. Emerald Mutual Fund Advisers Trust now owns 19,867 shares of the medical equipment provider’s stock worth $2,633,000 after buying an additional 152 shares during the last quarter. Lido Advisors LLC boosted its holdings in shares of Integer by 31.4% in the fourth quarter. Lido Advisors LLC now owns 2,742 shares of the medical equipment provider’s stock worth $363,000 after buying an additional 655 shares during the last quarter. Northern Trust Corp boosted its holdings in shares of Integer by 14.2% in the fourth quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider’s stock worth $55,974,000 after buying an additional 52,556 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Integer by 14.4% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 22,957 shares of the medical equipment provider’s stock worth $3,043,000 after buying an additional 2,891 shares during the last quarter. Finally, Dark Forest Capital Management LP purchased a new position in shares of Integer in the fourth quarter worth approximately $336,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.
Insider Activity
In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the business’s stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the sale, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 2.16% of the company’s stock.
Analyst Ratings Changes
View Our Latest Report on ITGR
Integer Trading Down 0.9%
Integer stock opened at $118.40 on Monday. The stock has a market cap of $4.13 billion, a P/E ratio of 35.24, a PEG ratio of 1.72 and a beta of 1.03. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. Integer Holdings Co. has a 1 year low of $104.93 and a 1 year high of $146.36. The firm’s 50 day moving average price is $118.43 and its 200-day moving average price is $129.77.
Integer (NYSE:ITGR – Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. The firm had revenue of $437.39 million for the quarter, compared to analysts’ expectations of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.14 earnings per share. On average, equities analysts predict that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.
About Integer
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Further Reading
- Five stocks we like better than Integer
- Want to Profit on the Downtrend? Downtrends, Explained.
- Constellation Powers Up With Reinforced AI Data Center Strategy
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Top Analyst-Rated Healthcare Stocks to Watch Now
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGR – Free Report).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.